Product
[212Pb]VMT-α-NET
1 clinical trial
9 indications
Indication
Neuroendocrine TumorsIndication
Lung Neuroendocrine TumorIndication
Neuroendocrine tumor of pancreasIndication
Neuroendocrine CarcinomaIndication
Neuroendocrine Tumor CarcinoidIndication
Carcinoid TumorIndication
ParagangliomaIndication
PheochromocytomaClinical trial
A Phase I/IIa First-in-Human Study of [212Pb]VMT-α-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine TumorsStatus: Recruiting, Estimated PCD: 2026-09-30